Literature DB >> 12401394

Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses.

Amer A Beg1.   

Abstract

Toll-like receptors (TLRs) have a crucial role in regulating immunity against microbial agents. Recent studies indicate that these receptors might also have an important role in regulating responses to endogenous stimuli, such as necrotic cells, heat-shock proteins and extracellular matrix breakdown products. Specifically, TLR2 and TLR4 were shown to mediate expression of inflammatory genes and trigger dendritic-cell 'maturation' by these agents. These intriguing findings suggest that the ancient family of TLRs are involved in the recognition, not only of microbes, but also of endogenous harmful stimuli. However, potential complications associated with microbial contamination of endogenous agents and the specific nature of in vivo responses induced by these agents remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401394     DOI: 10.1016/s1471-4906(02)02317-7

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  140 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

Review 4.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

5.  Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell Apoptosis.

Authors:  Nur Arfian; Khusnul Muflikhah; Sri Kadarsih Soeyono; Dwi Cahyani Ratna Sari; Untung Tranggono; Nungki Anggorowati; Muhammad Mansyur Romi
Journal:  Kobe J Med Sci       Date:  2016-07-05

6.  A two-hit mechanism for sepsis-induced impairment of renal tubule function.

Authors:  Bruns A Watts; Thampi George; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-16

7.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

Review 8.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

9.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.